Leukemia, Monocytic, Acute - 25 Studies Found
Terminated |
: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia :
|
Completed |
: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies :
|
Completed |
: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia :
|
Completed |
: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia :
|
Active, not recruiting |
: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia :
|
Completed |
: Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Active, not recruiting |
: Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia :
|
Active, not recruiting |
: Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders :
|
Completed |
: Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia :
|
Active, not recruiting |
: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia :
|